The Duke Human Vaccine Institute, located in Durham, North Carolina, was formed to support Duke University School of Medicine's efforts to develop vaccines and therapeutics for HIV and other emerging infections. From Wikipedia
HHS justifies the cuts by citing duplicative spending across HIV/AIDS programs.
